Valeo Chalks Up Another Milestone For Canadian Enoxaparin Biosimilars

Follows Backing To Be Listed On The Quebec Public Health Plan

 
• By Dean Rudge
  
Canadian flag waving_567680776_1200
Valeo's enoxaparin biosimilars are being licensed from Shenzhen Techdow Pharmaceutical • Source: Shutterstock

More from Biosimilars

More from Products